Context Therapeutics Inc is trading 8.48% down at $1.56 today, extending a sharp multi-day decline amid weak momentum and broader risk-off sentiment in the tech market.
- The stock has faced a significant downward trajectory since May 29, falling from a high of $2.85 to its current levels.
- In the absence of company-specific news or catalysts, the decline is attributed to technical selling and a shift in market sentiment toward growth-oriented sectors.